Funds holding BLUEJAY DIAGNOSTICS INC
ISIN US0956336087 · United States
- Fund holders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 18.6K $
- Share of capital
- 0.2 % of 4.5M shares on Aug 7, 2026
2 tracked funds declare this company: these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 8,887 | 18.2K $ | 0.20 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 183 | 375.2 $ | 0.00 % | as of Feb 28, 2026 ↗ |
Institutional managers
6 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 28,726 | 52.9K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 28,127 | 51.8K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,729 | 3.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 124 | 228 $ | as of Mar 31, 2026 |
| L1 Global Manager Pty Ltd | 120 | 220 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 3 | 6 $ | as of Mar 31, 2026 |
Declared shareholders of BLUEJAY DIAGNOSTICS INC
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Mitchell P. Kopin and 2 others | 9.99 % | 0 | as of Jun 3, 2026 · SCHEDULE 13G |
| Armistice Capital, LLC and 1 other | 4.99 % | 51,061 | as of Mar 31, 2026 · SCHEDULE 13G |
| Braeden Lichti and 1 other | 0.00 % | 0 | as of Jun 2, 2026 · SCHEDULE 13D |
| NorthStrive Fund II LP and 1 other | 0.00 % | 0 | as of Jun 2, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding BLUEJAY DIAGNOSTICS INC". https://titelia.com/en/stocks/bluejay-diagnostics-inc-US0956336087